NCT03015701
Clinical Trial Information
Trial Number: NCT03015701 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Miscellaneous
Trial Title:
Double Blind Randomized Trial of the Anti-Progestational Agent Mifepristone In The Treatment of Unresectable Meningioma
Study ID:
SWOG-9005 (S9005)
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT03015701-D3 | NCT03015701-D3-Dataset.csv provides adverse event data from both the blinded and open label treatment epochs. |
| NCT03015701-D2 | NCT03015701-D2-Dataset.csv will provide descriptive information on the patients receiving open label mifepristone after progressing from blinded placebo. |
| NCT03015701-D1 | The dataset NCT03015701-D1-Dataset.csv will allow users to reproduce efficacy analyses included in the aforementioned publication, which included primary and secondary efficacy results evaluating the mifepristone over placebo for the treatment of patients with unresectable meningioma in the SWOG phase III trial, S9005. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®